top of page

The CEO of Kano Therapeutics discusses circular single-stranded DNA, and life as a startup

Floris Engelhardt describes how her startup Kano is trying to use circular single-stranded DNA to correct gene length stretches of the genome.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page